Industry Verticals »

All Categories

Insights »

About TMR »

SNP Genotyping and Analysis Market

SNP Genotyping and Analysis Market (GeneChips, Taqman Allelic Discrimination, Pyrosequencing, AB SNPlex, Sequenom MassARRAY MALDI-TOF) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019

SNP genotyping and analysis is used mainly as a research tool to identify genomic variations that lead to different morphological traits and can determine the health and ancestry of plants and animals. The growth of the market is attributed mainly to the increasing demand from diagnostic research, pharmacogenomics and animal breeding along with technological drivers such as reducing cost of sequencing and introduction of innovative technologies. There is an increasing opportunity in developing and developed countries for genotyping services which will be within the reach of a common man and that will represent several billion dollars worth of business since people want to understand their genetic make-up in terms of aesthetic awareness (height, weight, obesity) or for serious diseases (diabetes, cancer, cardiovascular and others).

The market products are internally affected by power of substitution since there are around 8 to 10 different efficient techniques to carry out SNP genotyping such as TaqMan, SNPlex, Microarray, MALDI-TOF etc. With the completion of the Human Genome Project, over 2 million SNP’s have been added to global databases which in turn have initiated a series of research and development projects to understand potential of developing diagnostic tests through rapid genotyping techniques. A considerable amount of revenue is spent on research to developing diagnostic products similar to companion diagnostics which would enable to give us a preview of how a genome would unfold as an individual grows older. There is a high intensity of research in food crops such as rice, wheat, oats, corn, maize and other grasses. SNP genotyping in agriculture gained acceptance long before other applications. The GeneChip Rice 44K array offered by Affymetrix is one of the most popular platforms for rice genotyping which identifies variants that impact yield. Fluidigm’s SNPtype assays have been utilized by International Rice Research Institute which holds the world’s largest ex-situ collection of rice germplasm and plays a very large role in maintaining this repository.

The global market for SNP genotyping and analysis is expected to reach USD 9,485.2 million by 2019, up from USD 2,385.2 million in 2012, growing at a CAGR of 21.8% throughout the forecast period. Geographically, North America represents the largest market because of origin of several SNP technologies, awareness and increasing demand from pharmacogenomics and animal breeding sectors. The Asia-Pacific region is expected to record the highest CAGR of 23.1% during the forecast period as improving healthcare infrastructure, increasing investments by players in emerging economies such as China and India, and a large untapped research facilities segment will also boost growth of this market segment. Life Technologies Corporation, Illumina Inc., Affymetrix Inc, Fluidigm, Sequenom and Roche are some of the key vendors operating in this market.

    1. Introduction

        1.1. Report Description

        1.2. Market Segmentation

        1.3. Research Methodology

            1.3.1. Secondary Research

            1.3.2. Primary Research

            1.3.3. Statistical Models

            1.3.4. Assumptions and Stipulations

    2. Executive Summary

    3. Market Overview: Global SNP Genotyping & Analysis Market

        3.1. Rise of High Throughput Multiplex Genotyping

        3.2. Market Drivers

            3.2.1. Falling Prices in Sequencing will Drive Research and Development

            3.2.2. Increasing Demand from Breeding and Animal Livestock Continue to Support the Rise of Genotyping Market

            3.2.3. Increasing Incidences and Awareness of Genetic Diseases and Personalized Medicine to Drive the Growth

            3.2.4. Emerging Economies and expanding per capita income

        3.3. Market Restraints

            3.3.1. Imperfect Protocols Leading to Large Redundant Data

            3.3.2. Reimbursement is a Challenge

        3.4. Market Opportunities

            3.4.1. Increasing Demand for Affordable Genotyping Services

        3.5. Porter’s Five Forces Analysis: Global SNP Genotyping and Analysis Market

            3.5.1. Bargaining Power of Suppliers

            3.5.2. Bargaining Power of Buyers

            3.5.3. Threat of Substitutes

            3.5.4. Threat of New Entrants

            3.5.5. Competitive Rivalry

        3.6. Market Attractiveness Analysis: Global SNP Genotyping and Analysis Market, by Geography

    4. Global SNP Genotyping & Analysis Market, by Technologies, 2011-2019 (USD Million)

        4.1. Introduction

        4.2. SNP Genotyping by Microarrays and GeneChips

            4.2.1. Illumina

            4.2.2. Affymetrix

            4.2.3. Fluidigm

            4.2.4. Global SNP Genotyping Microarray/GeneChip Market, by Geography, 2011-2019 (USD million)

        4.3. Taqman Allelic Discrimination

            4.3.1. Global Taqman Allelic Discrimination Products Market, by Geography, 2011-2019 (USD million)

            4.3.2. Global Taqman Allelic Discrimination Market Break-Up 2012 (%)

        4.4. SNP Pyrosequencing

            4.4.1. Global SNP Pyrosequencing Market, by Geography, 2011-2019 (USD million)

        4.5. Applied Biosciences SNPlex

            4.5.1. Global AB SNPlex Market, by Geography, 2011-2019 (USD million)

        4.6. Sequenom MassARRAY MALDI-TOF

            4.6.1. Global Sequenom MassARRAY MALDI-TOF Market, by Geography, 2011-2019 (USD million)

        4.7. Other SNP Genotyping Technologies

            4.7.1. Global Other SNP Genotyping Technologies Market, by Geography, 2011-2019 (USD million)

    5. Global SNP Genotyping and Analysis Market, by Applications, 2011-2019 (USD Million)

        5.1. Overview

            5.1.1. Comparative Analysis: Global SNP Genotyping and Analysis Market by Application, 2012 & 2019 (%)

        5.2. Diagnostic Research

            5.2.1. Global SNP Genotyping and Analysis Market in Diagnostic Research, 2011-2019 (USD million)

        5.3. Pharmaceuticals and Pharmacogenomics

            5.3.1. Global SNP Genotyping and Analysis Market in Pharmaceuticals and Pharmacogenomics, 2011-2019 (USD million)

        5.4. Agricultural Biotechnology

            5.4.1. Global SNP Genotyping and Analysis Market in Agricultural Biotechnology, 2011-2019 (USD million)

        5.5. Breeding and Animal Livestock

            5.5.1. Global SNP Genotyping and Analysis Market in Breeding and Animal Livestock, 2011-2019 (USD million)

    6. Global SNP Genotyping and Analysis Market, by Geography, 2011-2019 (USD Million)

        6.1. Overview

            6.1.1. Comparative Analysis: Global SNP Genotyping and Analysis Market by Geography, 2012 & 2019 (%)

        6.2. North America

            6.2.1. North America SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

        6.3. Europe

            6.3.1. Europe SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

        6.4. Asia-Pacific

            6.4.1. Asia-Pacific SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

        6.5. Rest of the World (RoW)

            6.5.1. RoW SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

    7. Competitive Landscape

        7.1. Market Share by Key Players for the Global SNP Genotyping and Analysis Market, 2012. (%)

    8. Company Profiles

        8.1. Affymetrix, Inc.

            8.1.1. Company Overview

            8.1.2. Financial Overview

            8.1.3. Financial Overview

            8.1.4. Product Portfolio

            8.1.5. Business Strategies

            8.1.6. Recent Developments

        8.2. Douglas Scientific LLC

            8.2.1. Company Overview

            8.2.2. Product Portfolio

            8.2.3. Business Strategies

        8.3. Fluidigm

            8.3.1. Company Overview

            8.3.2. Financial Overview

            8.3.3. Product Portfolio

            8.3.4. Strategic Overview

            8.3.5. Recent Developments

        8.4. Illumina, Inc.

            8.4.1. Company Overview

            8.4.2. Financial Performance

            8.4.3. Product Portfolio

            8.4.4. Business Strategies

            8.4.5. Recent Developments

        8.5. Life Technologies Corporation

            8.5.1. Company Overview

            8.5.2. Financial Overview

            8.5.3. Product Portfolio

            8.5.4. Business Strategies

            8.5.5. Recent Developments

        8.6. PREMIER Biosoft

            8.6.1. Company Overview

            8.6.2. Product Portfolio

            8.6.3. Business Strategies

            8.6.4. Recent Developments and Acquisition

        8.7. ThermoFisher Scientific

            8.7.1. Company Overview

            8.7.2. Financial Overview

            8.7.3. Product Portfolio

            8.7.4. Business Strategies

        8.8. Sequenom, Inc.

            8.8.1. Company Overview

            8.8.2. Financial Performance

            8.8.3. Product Portfolio

            8.8.4. Business Strategies

            8.8.5. Recent Developments

    List of Tables

    TABLE 1: Market Snapshot: Global SNP Genotyping and Analysis Market

    TABLE 2: Global SNP Genotyping Microarray/GeneChip Market, by Geography, 2011-2019 (USD million)

    TABLE 3: Global Taqman Allelic Discrimination Products Market, by Geography, 2011-2019 (USD million)

    TABLE 4: Global SNP Pyrosequencing Market, by Geography, 2011-2019 (USD million)

    TABLE 5: Global AB SNPlex Market, by Geography, 2011-2019 (USD million)

    TABLE 6: Global Sequenom MassARRAY MALDI-TOF Market, by Geography, 2011-2019 (USD million)

    TABLE 7: Global Other SNP Genotyping Technologies Market, by Geography, 2011-2019 (USD million)

    TABLE 8: Global SNP Genotyping and Analysis Market, by Geography, 2011-2019 (USD Billion)

    List of Figures

    FIG. 1: SNP Genotyping and Analysis - Market Segmentation

    FIG. 2: Porter’s Five Forces Analysis: Global SNP Genotyping and Analysis Market

    FIG. 3: Market Attractiveness Analysis: Global SNP Genotyping and Analysis Market, by Geography

    FIG. 4: Global Taqman Allelic Discrimination Market Break-Up, 2012 ( %)

    FIG. 5: Comparative Analysis: Global SNP Genotyping and Analysis Market, by Application, 2012 & 2019 (%)

    FIG. 6: Global SNP Genotyping and Analysis Market in Diagnostic Research, 2011-2019 (USD million)

    FIG. 7: Global SNP Genotyping and Analysis Market in Pharmaceuticals and Pharmacogenomics, 2011-2019 (USD million)

    FIG. 8: Global SNP Genotyping and Analysis Market in Agricultural Biotechnology, 2011-2019 (USD million)

    FIG. 9: Global SNP Genotyping and Analysis Market in Breeding and Animal Livestock, 2011-2019 (USD million)

    FIG. 10: Comparative Analysis: Global SNP Genotyping and Analysis Market, by Geography, 2012 & 2019 (%)

    FIG. 11: North America SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

    FIG. 12: Europe SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

    FIG. 13: Asia-Pacific SNP Genotyping and Analysis Market Revenue, 2011-2019 (USD Million)

    FIG. 14: RoW SNP Genotyping and Analysis Market, 2011-2019 (USD Million)

    FIG. 15: Market Share Analysis: Global SNP Genotyping and Analysis Market, 2012 (%)

    FIG. 16: Affymetrix: Annual Sales Revenue (USD Million), 2010-2012

    FIG. 17: Fluidigm Corporation.: Annual Sales Revenue (USD Million), 2010-2012

    FIG. 18: Illumina, Inc.: Annual Sales Revenue (USD Million), 2010-2012

    FIG. 19: Life Technologies Corporation: Annual Sales Revenue (USD Million), 2010-2012

    FIG. 20: ThermoFisher Scientific: Annual Sales Revenue (USD Million), 2010-2012

    FIG. 21: Sequenom, Inc.: Annual Sales Revenue, USD Million, 2010-2012

Copyright © Transparency Market Research, Inc. All Rights reserved

SNP Genotyping and Analysis Market

Schedule a Call